Clinical trial
LAmbre™ Left Atrial Appendage Closure System Post-Market 2-5 Years Follow-Up Study
NCT03693092 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LAmbre™ Left Atrial Appendage Closure System Post-Market 2-5 Years Follow-Up Study
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 20, 2018
- Completion date
- July 31, 2020
- Enrollment
- 156 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.